Adaptin Bio (APTN) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
ADAPTIN BIO, INC.  (OTC: APTN)

ADAPTIN BIO, INC.

Officers & Directors


In 2025, the Company's executive officers were Michael J. Roberts, PhD, President and Chief Executive Officer; Simon C. Pedder, PhD, Executive Chairman; and Timothy L. Maness, CPA, Chief Financial Officer. Prior to their employment by the Company, Dr. Pedder received compensation under a compensation agreement, Dr. Roberts was compensated through MAC B Consulting LLC, which he owns, and Mr. Maness was compensated through Adamanteus LLC, which he owns, under consulting agreements. In 2025, the Company adopted an Equity Incentive Plan, making executives eligible for equity grants approved by the board of directors.








APTN Management Effectiveness APTN Revenue per Employee APTN Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.